You are here

  • Home
  • Archive
  • Volume 7, Issue 7
  • Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol

Article info

Article menu

Download PDFPDF

XML
Nutrition and metabolism
Protocol
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol

Authors

  • Seyed Ali Jazayeri-Tehrani Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran PubMed articlesGoogle scholar articles
  • Seyed Mahdi Rezayat Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran Department of Toxicology–Pharmacology, Faculty of Pharmacy, Pharmaceutical Science Branch, Islamic Azad University (IAUPS), Tehran, Iran PubMed articlesGoogle scholar articles
  • Siavash Mansouri National Iranian Oil Company (NIOC) Central Hospital, Tehran, Iran PubMed articlesGoogle scholar articles
  • Mostafa Qorbani Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran PubMed articlesGoogle scholar articles
  • Seyed Moayed Alavian Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatollah University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Milad Daneshi-Maskooni Department of Community Nutrition, Tehran University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Mohammad-Javad Hosseinzadeh-Attar Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Mohammad-Javad Hosseinzadeh-Attar; mhosseinzadeh{at}tums.ac.ir
View Full Text

Citation

Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, et al
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol
BMJ Open 2017;7:e016914. doi: 10.1136/bmjopen-2017-016914

Publication history

  • Received April 9, 2017
  • Revised May 24, 2017
  • Accepted May 26, 2017
  • First published July 10, 2017.
Online issue publication 
December 24, 2019
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/